Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.

Conjugated estrogens [12126-59-9]

Imprimer

Référence FC39669-10mg

Conditionnement : 10mg

Marque : Biosynth

Demander plus d'informations

CAS No

[12126-59-9]

Product Code

FC39669

MDL No

MFCD00240712

MOL file

Download

Chemical Formula

C₁₈H₁₉NaO₅S

Molecular Weight

370.4 g/mol

Smiles

[Na+].Cc1c(C)c2c(c(C)c1OS(=O)(=O)[O-])C(C)(C)C(C)(C)[C@]3(C)[C@]2(C)C(C)(C)C(C)(C)[C@@]4(C(=O)C(C)(C)C(C)(C)[C@@]34C)C(C)(C)C

Long Term Storage

store at 2°C - 8°C, close container well

Storage

store at 2°C - 8°C, close container well

Hazard Statement Code

H315, H319, H335

Precautionary Statement Code

P280, P302+P352, P304+P340, P305+P351+P338, P312, P403+P233, P501

GHS Information

Harmonized Tariff Codes

Switzerland: 29372300 - USA: 2937231050 - Slovakia: 2937230000 - UK: 2937230000 - China: 2937231100

Conjugated estrogens are a form of estrogen that is metabolized in the body. They are used for the treatment of postmenopausal symptoms, such as hot flashes and vaginal dryness, and also to prevent osteoporosis. Conjugated estrogens are given to women who have had their uterus surgically removed (hysterectomy) and to those who have had their ovaries removed (oophorectomy). Conjugated estrogens act by replacing the natural estrogen in the body, which is lost after menopause. The physiological effects of conjugated estrogens include increased energy metabolism and an increase in HDL cholesterol levels. These hormones can be detected in sewage effluent and wastewater treatment plants, which may lead to estrogenic effects on women who work there or use these water supplies.

Specification

English

CoA (Example)

FC39669 CofA

MSDS

Request MSDS

TSE / BSE Statement

TSE-BSE declaration Conjugated estrogens FC39669

Retest Statement

Retest Statement Conjugated estrogens FC39669